# I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

> **NCT07186478** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hasanuddin University** · enrollment: 112 (estimated)

## Conditions studied

- Pulmonary Tuberculosis
- Hypoalbuminemia

## Interventions

- **DRUG:** Investigational Drug
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07186478
- **Lead sponsor:** Hasanuddin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-17
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-10-20
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186478, "I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07186478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*